India’s oncology healthcare ecosystem continues to attract investor interest as cancer care startup Oncare has secured Rs 27 crore (approximately $4 million) in a Series A funding round led by Sky Impact Capital. The funding round also saw participation from Huddle Ventures, Lotus Herbal Group, SteerX, and Tremis Capital, reflecting growing confidence in tech-enabled, accessible cancer treatment models.
The fresh capital infusion comes at a time when demand for structured and affordable oncology services is rising across India, particularly beyond metropolitan regions.
Expansion Plans and Technology Investments
Oncare plans to use the newly raised funds to expand its footprint into additional metro markets, as well as tier-II and tier-III cities where access to specialised cancer treatment remains limited. The company is also prioritising investments in technology infrastructure aimed at streamlining clinical workflows, improving care coordination, and enhancing the overall patient experience.
By leveraging technology, Oncare intends to standardise treatment protocols, reduce operational inefficiencies, and ensure consistent quality of care across its centres. The startup is focused on building a scalable oncology platform that balances affordability with clinical excellence.
Building a Distributed Oncology Platform
Founded in 2023 by Amar Sneh and Deepak Kumar, Oncare operates a distributed oncology care model designed to integrate medical, surgical, and radiation oncology services within accredited hospital environments. Unlike traditional hospital-heavy expansion strategies, Oncare follows a capital-efficient approach by partnering with existing hospital infrastructure.
This model enables the company to reduce upfront capital expenditure while accelerating market entry and improving patient accessibility. By embedding oncology services into established hospitals, Oncare ensures patients receive comprehensive cancer treatment under one coordinated system.
Within just three years of its launch, the company has established four oncology centres across the Delhi NCR region. The rapid scaling highlights strong demand for structured cancer treatment services and reflects the startup’s operational execution capabilities.
Addressing India’s Growing Cancer Burden
India continues to witness a steady rise in cancer cases, driven by lifestyle changes, environmental factors, and increased awareness leading to higher diagnosis rates. Despite advancements in medical science, access to standardised and affordable oncology care remains uneven, particularly in smaller cities.
Many patients are forced to travel to major metros for treatment, increasing financial and emotional stress. By expanding into tier-II and tier-III cities, Oncare aims to bridge this accessibility gap and bring high-quality cancer treatment closer to patients’ homes.
The startup’s distributed model is designed to tackle fragmentation in oncology care by integrating diagnostics, treatment planning, and therapy execution under a coordinated platform. This approach not only improves outcomes but also enhances patient confidence and compliance during long-term treatment cycles.
Investor Confidence in Oncology Startups
Funding activity in India’s oncology segment has gained momentum over the past few years, indicating rising investor interest in specialised healthcare platforms.
Recently:
-
4baseCare raised Rs 90 crore in a funding round led by prominent investors including Ashish Kacholia and Lashit Sanghvi.
-
Everhope Oncology secured $10 million in seed funding.
-
MOC Cancer Care & Research Centre raised $18 million in a round led by Elevation Capital.
-
Other oncology-focused startups such as ErlySign and OneCell Diagnostics have also attracted capital.
This wave of funding signals that oncology is emerging as a high-impact, long-term investment category within India’s healthtech and hospital infrastructure ecosystem.
Scaling Nationwide: The Road Ahead
With Series A funding secured, Oncare is now targeting nationwide expansion. Its strategy revolves around three key pillars:
-
Geographic Expansion – Establishing oncology centres in high-demand urban clusters and underserved regions.
-
Technology Enablement – Investing in digital platforms to improve clinical coordination, patient tracking, and treatment standardisation.
-
Patient-Centric Experience – Enhancing care delivery through better communication, streamlined processes, and transparent treatment pathways.
The capital-efficient partnership model also gives Oncare flexibility to scale faster without building standalone hospitals, reducing risk while increasing reach.
The Future of Affordable Oncology in India
As India’s healthcare landscape evolves, specialised care platforms are gaining prominence. Oncology, in particular, requires multidisciplinary coordination, high-end diagnostics, and consistent treatment protocols. Startups like Oncare are attempting to modernise cancer care delivery by combining medical expertise with operational efficiency.
With rising awareness, improved screening practices, and growing insurance penetration, demand for organised cancer treatment services is expected to increase steadily. Companies that can combine affordability, accessibility, and technology-driven standardisation are likely to shape the next phase of healthcare transformation.
Oncare’s Series A funding marks another milestone in India’s expanding oncology startup ecosystem. As it moves beyond Delhi NCR and into new markets, the company aims to make structured cancer care more accessible to millions of patients across the country.
Ruchi Kumar is the associate editor at Entrepreneur News Network and TVW News India, where she leads editorial strategy, brand storytelling, and startup ecosystem coverage. With a strong focus on innovation, business, and marketing insights, he curates impactful narratives that spotlight India’s evolving entrepreneurial landscape.